Document Detail


CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection.
MedLine Citation:
PMID:  20573822     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Regulatory CD4(+) T cells have been shown to be important in limiting immune responses, but their role in respiratory viral infections has received little attention. Here we observed that following respiratory syncytial virus (RSV) infection, CD4(+) Foxp3(+) CD25(+) natural regulatory T-cell numbers increased in the bronchoalveolar lavage fluid, lung, mediastinal lymph nodes, and spleen. The depletion of CD25(+) natural regulatory T cells prior to RSV infection led to enhanced weight loss with delayed recovery that was surprisingly accompanied by increased numbers of activated natural killer cells in the lung and bronchoalveolar lavage fluid on day 8 postinfection. Increased numbers of neutrophils were also detected within the bronchoalveolar lavage fluid and correlated with elevated levels of myeloperoxidase as well as interleukin-6 (IL-6) and gamma interferon (IFN-gamma). CD25(+) natural regulatory T-cell depletion also led to enhanced numbers of proinflammatory T cells producing IFN-gamma and tumor necrosis factor alpha (TNF-alpha) in the lung. Despite these increases in inflammatory responses and disease severity, the viral load was unaltered. This work highlights a critical role for natural regulatory T cells in regulating the adaptive and innate immune responses during the later stages of lung viral infections.
Authors:
Debbie C P Lee; James A E Harker; John S Tregoning; Sowsan F Atabani; Cecilia Johansson; Jürgen Schwarze; Peter J M Openshaw
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-06-23
Journal Detail:
Title:  Journal of virology     Volume:  84     ISSN:  1098-5514     ISO Abbreviation:  J. Virol.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-06     Completed Date:  2010-09-16     Revised Date:  2011-07-25    
Medline Journal Info:
Nlm Unique ID:  0113724     Medline TA:  J Virol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  8790-8     Citation Subset:  IM    
Affiliation:
Department of Respiratory Medicine and Centre for Respiratory Infection, National Heart and Lung Institute, Imperial College, St Mary's Campus, Norfolk Place, London W2 1PG, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adaptive Immunity*
Animals
Cell Line
Female
Humans
Immunity, Innate*
Interferon-gamma / immunology
Interleukin-2 Receptor alpha Subunit / immunology
Interleukin-6 / immunology
Lung / immunology,  pathology
Mice
Mice, Inbred BALB C
Respiratory Syncytial Virus Infections / immunology*,  pathology,  virology
Respiratory Syncytial Viruses / immunology,  physiology*
T-Lymphocytes, Regulatory / immunology*,  virology
Grant Support
ID/Acronym/Agency:
087805/Z/08/Z//Wellcome Trust
Chemical
Reg. No./Substance:
0/Interleukin-2 Receptor alpha Subunit; 0/Interleukin-6; 82115-62-6/Interferon-gamma
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Delaying the expression of herpes simplex virus type 1 glycoprotein B (gB) to a true late gene alter...
Next Document:  Temporal and spatial resolution of type I and III interferon responses in vivo.